TrialJCO precision oncology2022
Phase II Study of Taselisib in
Ian E Krop et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it
TrialJCO precision oncology2022
Ian E Krop et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.